All Biotech News

List of articles in category All Biotech News
Title	Published Date
Pureos Bioventures Closes First Fund with USD 170 Million	09/23/2020
Immune Regulation Limited Raises £40.6 Million / $53.4 Million Series B Equity Financing	09/21/2020
Live Event: Recent Austrian Corona Measures Validate New euroPLX Concept	09/15/2020
First Patients Treated in First-in-Human Trial for ACTISEAL® - Polyganics' Innovative Liver and Pancreas Sealant Patch	09/15/2020
Immune Regulation Ltd Receives Notice of Allowance for New U.S. Patent for its Novel Protein with Anti-Inflammatory Properties	09/08/2020
IcanoMAB GmbH Founded with Private Funding to Develop Precision Canonical Monoclonal Antibodies in Oncology, Immune-Modulation, Acute Inflammation and Most Urgently for Covid-19	09/07/2020
New Concept Allows Physical Partnering Event	09/07/2020
IME Medical Electrospinning Secured € 3 Million in New Financing From Dutch VCs Borski Fund, Lumana Invest, TIIN Capital and From Rabobank to Further Expand its Medispin XL Production Platform	09/03/2020
Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer	09/03/2020
BioVersys Announces CHF 19 Million Financing to Advance Novel AMR Candidates into Clinical Development	09/01/2020
SOTIO Acquires Rights to BOXR CAR-T Platform and Products from Unum Therapeutics	08/31/2020
3D Cell Culture Systems in Cancer Organoids Reveal Drug Efficacy that is Undetectable in Traditional 2D Monolayer Systems	08/26/2020
Byondis Initiates Phase I Study of ADC [Vic-]Trastuzumab Duocarmazine + Niraparib in HER2-Expressing Solid Tumors	08/25/2020
New Nasal Gel Evaluated for its Protective Action Against Human Rhinovirus 16 (HRV-A16) Infection in Nasal Epithelial Cells	08/24/2020
MC2 Therapeutics Announces Collaboration Agreement with EPI Health on Commercialization of Newly Approved Psoriasis Drug, WYNZORA® Cream, in the US	08/24/2020
Hercules' AhR Inhibitor HP163 Blocks Viral Replication in Zika Infection and Potentially in Covid-19	08/20/2020
Byondis Announces Appointment of Chief Financial Officer	08/19/2020
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875	08/11/2020
Dutch Saillant Therapeutics to Develop Generic Virus Inhibiting Therapy Based on Activation of a Cellular Master Regulator, Ending Virus Replication	08/11/2020
A Strong Signal in Turbulent Times: Vetter Achieves Carbon Dioxide-Neutral Levels	07/29/2020
Intravacc and Celonic to Develop and Produce a Novel COVID-19 Vaccine	07/29/2020
Digital Health: Clinical Study Published in “Ophthalmology” Demonstrates Implandata’s EYEMATE System Benefits Glaucoma Patients	07/27/2020
MC2 Therapeutics Announces U.S. Food and Drug Administration Approval of Wynzora® Cream (calcipotriene and betamethasone dipropionate w/w 0.005%/0.064%) for Adults with Plaque Psoriasis	07/22/2020
Byondis Initiates Phase II Study of Antibody-Drug Conjugate [Vic-]Trastuzumab Duocarmazine in Advanced Endometrial Cancer	07/15/2020
SOTIO Announces First Patient Dosed in Part B of Phase 1/1b Study with SO-C101 in Combination with Pembrolizumab in Patients with Solid Tumors	07/14/2020
Toxys Appoints Susan Swarte as New Non-Executive Board Member	07/14/2020
Vetter Further Expands its Development Service with New Site in Austria	07/08/2020
Rentschler Biopharma and Vetter Team Up with Joint Goal to Simplify Processes and Optimize Time-To-Market	07/06/2020
Immune Regulation Ltd Partners with DynPort Vaccine Company to Advance its Drug Product for COVID-19 into Clinical Trials	07/06/2020
osteolabs GmbH Provides Further Validation for Use of OsteoTest in Osteoporosis and Early-Stage Kidney Malfunction	07/02/2020

Page 24 of 88